Coronary Artery Disease
Conditions
Interventions
Intervention Group :On the basis of conventional treatment, include the 'Electrocardiogram Network' platform for assisted management, implementing a digital chronic disease management model.
Control group:Standardized routine management based on current guidelines
Sponsors
People's Hospital of Jiang'an County
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years, no gender restriction; 2. Confirmed diagnosis of coronary heart disease (verified by coronary angiography, coronary CTA, previous PCI or CABG, or meeting relevant guideline diagnostic criteria); 3. In a stable phase, with no acute or unstable cardiovascular events in the past 4 weeks; 4. Presence of at least 2 cardiovascular metabolic risk factor abnormalities, with at least 1 being dyslipidemia (such as elevated LDL-C or currently receiving lipid-lowering treatment); 5. Able to understand the study content and complete follow-up; 6. Willing to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Presence of acute or unstable cardiovascular events within the past 4 weeks (such as acute myocardial infarction, unstable angina, acute heart failure, etc.); 2. Expected life expectancy <1 year; 3. Presence of severe mental, cognitive, or communication disorders that prevent completion of follow-up or relevant assessments; 4. Severe liver or kidney dysfunction, or other serious systemic diseases that may affect the judgment of study results; 5. Major interventions within the past 3 months that may significantly affect lipid, blood pressure, or glucose metabolism; 6. Currently participating in other clinical trials; 7. Other conditions deemed by the investigator as unsuitable for enrollment or difficult to complete follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in cardiometabolic composite score (?CCS) at 6 months; | — |
Secondary
| Measure | Time frame |
|---|---|
| LDL-C target achievement rate at 6 months (LDL-C <1.8 mmol/L);Major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and urgent revascularization);Hospitalization and readmission (all-cause hospitalization, cardiovascular hospitalization, and readmission rates);Adherence measures (medication adherence, follow-up adherence, platform use adherence, and lifestyle adherence);Patient-reported outcomes (SAQ, PHQ-9, GAD-7, and PSQI scores);Angiographic outcomes in the PCI subgroup( late lumen loss ); | — |
Countries
China
Contacts
Public ContactChang Cheng
People's Hospital of Jiang'an County
Outcome results
None listed